Sirona Biochem Statistics
Total Valuation
Sirona Biochem has a market cap or net worth of 266.
| Market Cap | 266 |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, June 24, 2026.
| Earnings Date | Jun 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sirona Biochem has 265.51 million shares outstanding.
| Current Share Class | 265.51M |
| Shares Outstanding | 265.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.70% |
| Owned by Insiders (%) | 5.30% |
| Owned by Institutions (%) | n/a |
| Float | 251.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -0.02 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -148.11% |
| Return on Invested Capital (ROIC) | -1,489.58% |
| Return on Capital Employed (ROCE) | 144.49% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sirona Biochem has paid 2,052 in taxes.
| Income Tax | 2,052 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.73% in the last 52 weeks. The beta is 0.25, so Sirona Biochem's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -72.73% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 39.30 |
| Average Volume (20 Days) | 38,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sirona Biochem had revenue of -11,846 and -1.93 million in losses. Loss per share was -0.01.
| Revenue | -11,846 |
| Gross Profit | -58,993 |
| Operating Income | -1.64M |
| Pretax Income | -1.93M |
| Net Income | -1.93M |
| EBITDA | -1.63M |
| EBIT | -1.64M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 24,340 in cash and 2.40 million in debt, with a net cash position of -2.38 million or -0.01 per share.
| Cash & Cash Equivalents | 24,340 |
| Total Debt | 2.40M |
| Net Cash | -2.38M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.51M |
| Book Value Per Share | -0.01 |
| Working Capital | -1.14M |
Cash Flow
| Operating Cash Flow | -1.47M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 7,215 |
| Net Borrowing | 947,995 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 13,845.18% |
| Pretax Margin | 16,277.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sirona Biochem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.79% |
| Shareholder Yield | -2.79% |
| Earnings Yield | -725,662.78% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sirona Biochem has an Altman Z-Score of -87.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -87.92 |
| Piotroski F-Score | 2 |